Literature DB >> 7236872

The effect of antacid, metoclopramide, and propantheline on the bioavailability of metoprolol and atenolol.

C G Regårdh, P Lundborg, B A Persson.   

Abstract

Concomitant administration of antacid increased the maximum concentration (Cpmax) and the area under the plasma concentration-time curve (AUC) of 100 mg oral dose of metoprolol by 25 per cent (p less than 0.05) and 11 per cent (p less than 0.1) respectively. For atenolol the opposite effect was observed and Cpmax and AUC were decreased by 37 and 33 per cent respectively (p less than 0.02). In both cases the antacid did not affect the time-course of atenolol in the plasma or its bioavailability. Propantheline prolonged the absorption phase of atenolol and the time of peaking (tmax) was shifted from 2.1 to 4.5 h. Cpmax of atenolol was essentially unchanged by propantheline pretreatment while the AUC was increased by 36 per cent. It is concluded that the negative effect of the antacid on the bioavailability of atenolol is caused by a reduction in the in vivo dissolution rate due to increased gastric pH. The positive effect of propantheline might be due either to more efficient absorption of atenolol in the upper part of the intestine or more extensive dissolution of the drug as a result of prolonged contact with gastric juice or a combination of these factors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236872     DOI: 10.1002/bdd.2510020109

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  13 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 2.  Clinically significant drug interactions with antacids: an update.

Authors:  Ryuichi Ogawa; Hirotoshi Echizen
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

3.  Variability of beta-blocker pharmacokinetics in young volunteers.

Authors:  D B Jack; C P Quarterman; R Zaman; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 4.  Pharmacokinetic drug interactions with gastrointestinal motility modifying agents.

Authors:  J M Greiff; D Rowbotham
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

5.  Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.

Authors:  W Kirch; H Spahn; H Köhler; E E Ohnhaus; E Mutschler
Journal:  Klin Wochenschr       Date:  1982-11-15

6.  The influence of gastrointestinal transit on drug absorption in healthy volunteers.

Authors:  S A Riley; F Sutcliffe; M Kim; M Kapas; M Rowland; L A Turnberg
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

7.  Effect of cisapride and metoclopramide on digoxin bioavailability.

Authors:  W Kirch; H D Janisch; S R Santos; U Duhrsen; P Dylewicz; E E Ohnhaus
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Oct-Dec       Impact factor: 2.441

Review 8.  Drug interactions with antacids. Mechanisms and clinical significance.

Authors:  D C Sadowski
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

Review 9.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

10.  Pharmacological attempts to improve the bioavailability of oral etoposide.

Authors:  S P Joel; P I Clark; L Heap; L Webster; S Robbins; H Craft; M L Slevin
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.